Correlation Between Bristol Myers and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and XORTX Therapeutics, you can compare the effects of market volatilities on Bristol Myers and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and XORTX Therapeutics.
Diversification Opportunities for Bristol Myers and XORTX Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bristol and XORTX is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and XORTX Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.65 times more return on investment than XORTX Therapeutics. However, Bristol Myers Squibb is 1.55 times less risky than XORTX Therapeutics. It trades about 0.2 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 5,266 in Bristol Myers Squibb on August 31, 2024 and sell it today you would earn a total of 661.00 from holding Bristol Myers Squibb or generate 12.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. XORTX Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| XORTX Therapeutics |
Bristol Myers and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and XORTX Therapeutics
The main advantage of trading using opposite Bristol Myers and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| XORTX Therapeutics vs. Cue Biopharma | XORTX Therapeutics vs. Eliem Therapeutics | XORTX Therapeutics vs. Inhibrx | XORTX Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |